A retrospective study evaluating the effects of emtricitabine/tenofovir alafenamide (F/TAF)-based regimens switching from emtricitabine/tenofovir disoproxil fumarate (F/TDF)
Latest Information Update: 01 Oct 2019
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 01 Oct 2019 New trial record